Class Action Article

  • File A Talcum Powder Lawsuit: Talcum Powder Ovarian Cancer Lawsuits Talcum Powder Fallopian Tube Cancer Lawsuits Baby  Powder Ovarian Cancer Lawsuits Filed If you or a loved one used talcum powder products and were diagnosed with ovarian cancer, or fallopian tube can...

Class Action News

Drug Class Actions

  • Taxotere Lawyers for Permanent Hair Loss: Taxotere Baldness Lawyers For  Permanent Hair Loss Lawsuits Have you received Taxotere for breast cancer? Taxotere can result in hair loss or baldness  that is permanent. Taxotere  is a chemotherapy drug used for the treatment of breas...

Medical Device Lawsuits

  • Get A Hernia Mesh Lawyer | Hernia Mesh Lawsuits Filed: The hernia mesh lawyers of Class Action Lawyer Network are filing hernia mesh lawsuits for victims of a failed hernia mesh. We have Ethicon, Bard and Cook hernia mesh lawyers. Hernia Mesh Lawsuits Filed  For: Ethicon: Physiomesh Pro...

Posts Tagged ‘Vaginal mesh class action’

Women With Dow Corning Breast Implants Are Still Waiting AS Vaginal Mesh Bellwether Trials Begin

Written by lisaspitzer on . Posted in Class MDL Class Action News

The Dow Corning Breast Implant Class Action was the largest class action in history effecting women until the vaginal mesh. Now women are watching the Bellwether trials hoping for justice as women with Dow Corning Breast Implants are still waiting.

Claimants in Dow Corning Breast Implant Lawsuit Waiting

As one woman says:

We have all been waiting for our disbursement from the Court that was awarded us because of our problems with the Dow Corning Breast Implant Lawsuit. This award was made over 20 years ago. Please feel free to use this letter in your pursuit of your share of the proceeds from this lawsuit. I am interested in getting this settled and getting paid, and I know you are, also.

Will women destroyed by the vaginal mesh have the same problems?


March 4, 2013


This letter is to all claimants under the Dow Corning Breast Implant Suit.

We have been told that an oral argument is being made before the U.S. Court of Appeals for the 6th Circuit as to whether or not Dow Corning can claim a credit for interest earned on the Initial Payment that was made before the Effective Date of the Plan. It was successfully argued by the CAC that the bankruptcy settlement provided that the claimants, not Dow Corning, would get the benefit of the interest earned on the Initial Payment.

The hearing went well and the Court took the Issue under advisement. We expect a ruling to come sometime in 2013. So far there are not any updates on this ruling.

The Courts need to realize that Dow has been making appeals on this case for too many years. Dow Corning has let it be known that there is plenty of money in its Settlement Fund to pay the current claimants and those who may claim in the future, but they continually object to actually making these payments, hoping to be able to keep any and all interest due on these payments. It has been argued that the claimants are to get the interest and this ruling is what the claimants are waiting on SO THAT THEY CAN FINALLY GET PAID.

As one of the claimants, I feel that after almost 20 years of trying to collect from Dow Corning, I should be the one to benefit from the additional interest earned by the Settlement Fund, not Dow Corning or their attorneys. The accrued interest aside, I want to be paid now because of the financial burden imposed on myself and the thousands of other claimants over the years. Personally, I am in danger of losing my home and car. It is hard for me to pay for medicine and food. Even though food stamps are available, many states are reducing the amounts paid out. My attorney surely deserves his reward after all the years of providing me with support and advice.

These premium payments could be a welcome injection into the critical financial situation in which most of the country finds itself. These women claimants have had to put off purchases that are normally made each year, such as insurance, new clothes, new vehicles to replace not-so-reliable old ones, and other items that many persons take for granted.

Women have really been taken advantage of in so many ways – almost comparable to being raped. They have suffered mentally, financially and physically. Time moves very slowly when you think you have been forgotten and the Courtroom seem to go on and on. I will be 78 years old in September of 2011. I have waited 20 years for the premium payments since I first applied as a claimant. I doubt I can wait another 20 years.

How long can Dow Corning use the Courts to avoid paying these poor women?

As we look at the past for women whose lives were destroyed by Dow Corning Breast Implants we can only wonder what the future holds for 1000's of vaginal mesh victims. Our vaginal mesh lawyers are here to help you. Our Breast Implant lawyers are here to help you. We are lawyers helping woman.

J & J Sold Vaginal Mesh Without Approval, Vaginal Mesh Lawyers filing Vaginal Mesh Lawsuits For Injured Women

Written by lisaspitzer on . Posted in Medical Device Lawsuits, Transvaginal mesh

Vaginal Mesh Multi District Litigation lawsuits are being filed by the Vaginal mesh Multi District  litigation division of Class Action Lawyer Network. It appear Johnson and Johnson was selling the vaginal mesh product on it's own initiative.

J&J Sold Vaginal Mesh Implant After Sales Halt Ordered
By DVoreacos and A Nussbaum – Jun 26, 2012 2:23 PM ET

Johnson & Johnson (JNJ), the biggest health-care products maker, continued to sell a vaginal mesh implant for nine months after U.S. regulators told the company to stop marketing the device, according to court records.

The U.S. Food and Drug Administration told J&J in a letter on Aug. 24, 2007, to halt Gynecare Prolift sales until the agency decided whether the device was “substantially equivalent” to other products on the market. The FDA cited the “potential high risk for organ perforation” when surgeons insert the mesh vaginally to support weakened pelvic tissue.
Enlarge image J&J Sold Vaginal Mesh Implant After FDA Ordered Sales Halted

On June 5, J&J said it will stop selling four vaginal mesh implants including the Prolift. Photographer: Daniel Acker/Bloomberg

“You may not market this device until you have provided adequate information” on 16 potential deficiencies and received FDA approval, the agency told New Brunswick, New Jersey-based J&J in the letter. “If you market the device without conforming to these requirements, you will be in violation of the Federal Food, Drug and Cosmetic Act.”

The FDA cleared the device in May 2008 without ordering sanctions, after nine months of negotiations with J&J’s Ethicon unit. The company faces more than 1,400 lawsuits by women who said the mesh caused organ perforation, pain, scarring and nerve damage. Lawyers for the women said the device’s approval history could increase J&J’s cost to resolve the litigation.

J&J began selling the Prolift in 2005 without filing a new application after determining on its own that it was substantially similar to the Gynemesh, a company device already approved by the FDA, said Matthew Johnson, a J&J spokesman, in an e-mail. The device maker relied on FDA guidance for when companies must submit new applications, Johnson said.

The FDA disagreed with J&J’s interpretation and required a new application that prompted questions in the August 2007 letter, Morgan Liscinsky, an agency spokeswoman, said in an e- mail.

J&J faced no sanctions because the FDA determined that the company applied the guidance in good faith and it “promptly complied” when the agency required a new application, Liscinsky said.
Fines, Injunctions

Sanctions for selling products without approval may include fines, injunctions against a company or senior managers and the seizure of illegally marketed devices, Liscinsky said.

The August 2007 letter was “only one part of an extended dialogue with FDA in 2007-08, and it is out of context,” Johnson said in the e-mail. “Throughout this process, our actions were responsible, appropriate and consistent with FDA regulations.”

Henry G. Garrard III, a lawyer who represents women suing in federal court in Charleston, said the FDA’s failure to take additional steps to halt Prolift sales or to sanction J&J raises questions about the agency’s power to protect patients.

“Companies know the FDA has little enforcement ability and scarce resources,” Garrard, of Blasingame, Burch, Garrard & Ashley PC in Athens, Georgia, said in a telephone interview.

“Every woman in America who has been implanted with these devices absolutely should be outraged,” he said. “They should be mad at the company because the company knew they could get away with it.”
‘Water Pistol’

The Prolift negotiations point out “the industry’s ability to shrug off FDA enforcement,” said Erik Gordon, a business professor at the University of Michigan, in an e-mail. “If companies can get away with selling products they aren’t supposed to sell, the FDA is a sheriff packing a water pistol.”

The U.S. Senate is to vote today on changes to the FDA’s device-review system, which has drawn scrutiny for allowing implants like vaginal mesh on the market without human testing.

The bill increases funding for reviews and the FDA’s power to order safety studies after a product is cleared. It doesn’t include powers sought by consumer groups to let the FDA require clinical trials for more implants before they reach the market. The House of Representatives approved the measure last week.
Implants Threaded

Surgeons thread mesh implants through vaginal incisions and use the devices to treat incontinence or pelvic organ prolapse, a condition in which weakened muscles fail to support organs. Almost 300,000 were used in U.S. women in 2010, the FDA estimated last year.

An FDA database of reported malfunctions, deaths and serious injuries shows the agency received 123 complaints about the Prolift from 2005 to May 15, 2008, when the device won clearance. The company said in a September 2007 letter to regulators that reported problems accounted for less than 0.5 percent of sales for both Gynemesh and Prolift.

An agency report in July found a fivefold jump in deaths, injuries or malfunctions tied to prolapse mesh inserted vaginally. In January, the FDA ordered J&J, Murray Hill, New Jersey-based C.R. Bard Inc. (BCR) and other manufacturers to study organ damage and complications related to the products.
Sales Estimates

Manufacturers including J&J sold about $175 million worth of prolapse mesh worldwide and another $295 million for incontinence treatments in 2010, C.R. Bard executives estimated on a conference call that year. Even for top sellers of the devices, the products made up no more than 2 percent of company sales, said Michael Matson, a Mizuho Securities USA analyst in New York.

The numbers declined as lawsuits were filed, he said in a telephone interview.

“The doctors aren’t implanting them,” Matson said. “The patients don’t want them.”

On June 5, J&J said it will stop selling four vaginal mesh implants including the Prolift. The move wasn’t a recall and J&J remains confident in the safety and effectiveness of the devices, Johnson said. The company won’t withdraw the Prolift before its “planned discontinuation” of the mesh products over the next three to nine months, he said.

“Our decision to discontinue these products is based on their commercial viability in light of changing market dynamics,” he said.
Label Update

In letters to state and federal judges, the company said that it will update labeling for one device, the Gynemesh, to allow only abdominal, not vaginal, insertion.

The FDA learned of the Prolift after J&J cited it in an application to sell a related device, the Prolift+M, Liscinsky said. The agency told J&J to file for the Prolift as well, and it combined the review for both devices before the August 2007 letter.

“Due to the complexity of this procedure and potential high risk for organ perforation, bench testing is not sufficient to demonstrate device safety and efficacy,” the FDA said in the letter. Bench testing refers to laboratory testing to determine how a device will function in a person.

In the August 2007 letter, the FDA asked 16 questions about the Gynemesh and Prolift, which are made of the same nonabsorbable polymer. The Prolift kit includes pre-shaped mesh and instruments to help surgeons implant the device.

One FDA query was about a “significant number” of complications from 2004 to 2007 on the earlier device, the Gynemesh. The agency got 174 such reports, including for infection, abscess and organ perforation. Most of the cases required additional surgery.

The agency’s letter also found that labeling for the Prolift+M device was deficient because it couldn’t support claims that the mesh has “elastic properties that allow adaptation to physiological stresses.” In its response, J&J agreed to remove that claim.

Many of the documents unsealed last month include e-mails between J&J and the FDA over the wording of product labeling about the benefits and risks.

Six days before the FDA cleared the Prolift, J&J agreed in a written response to say in the label that the safety and effectiveness of the device, compared to conventional surgical repair without mesh, “have not been demonstrated in randomized controlled clinical trials.”

Rather, J&J wrote, the substantial equivalence to earlier approved devices had been demonstrated through other tests.

The federal cases are In re Ethicon Inc., Pelvic Repair System Products Liability Litigation, 12-md-02327, U.S. District Court, Southern District of West Virginia (Charleston).

If you have a Gynecare Vaginal mesh and are having complications call us today. We are also accepting cases for Yaz, Yasmin, Mirena IUD, NuvaRing and all drugs and devices harming women.


Mirena IUD Lawyers, Vaginal Mesh lawsuit Lawyers

Written by lisaspitzer on . Posted in Medical Device Lawsuits

Mirena IUD lawyers are reviewing cases for the Mirena IUD for a perforated uterus only. Vaginal mesh lawyers are filing lawsuits for the severe complications resulting from the Prolene vaginal mesh and bladder sling.

Women throughout the United States who received Mirena IUD for birth control are calling the Mirena IUD Helpline with serious complications. The stories we are hearing include complications of the  implanted device where it has punctured or perforated the uterus. Many of our callers tell us the Mirena IUD has migrated through the intra-abdominal cavity.  Many of the stories we hear are consistent with the following

  •     Perforation of the Uterus or nearby organs
  •     Migration of the device where it becomes embedded in the Uterus or abdominal cavity
  •     Expulsion of the IUD
  •     The need to have the IUD surgically removed and difficulty in finding the IUD

Our Mirena Silicone IUD lawyers are reviewing cases to seek justice for injured women. The lasuits will claim that the manufacturer failed to adequately warn women about the risk of Mirena perforating the Uterus and the additonal complications where the device punctures or embeds in the uterine wall. This can lead to infections, internal scarring and the need for surgery to repair the torn tissues.

In some cases, the Mirena IUD may migrate through the uterine wall, causing serious intestinal problems or other internal injuries, including  serious damage to nearby organs.

The Mirena IUD is manufactured by Bayer pharmaceuticals who has recently settled on Blood Clots from Yaz birth control pills. Mirena is a soft, flexible IUD that releases small amounts of hormone locally into your uterus. According to ther manufacturer  "It gives you birth control you can count on" However that is not taking into account the side effects we have been hearing daily.

Call now to speak to a Mirena IUD lawyer. We are also handling Yaz birth control pills lawsuits and the vaginal mesh litigations.

Mirena IUD and A Perforated Uterus

Written by Class Action Lawyer on . Posted in Class MDL Class Action News

The Mirena IUD along with the vaginal mesh, Yaz, Yasmin are devices and Drugs harming women. Mirena IUD Class Action lawyers are currently reviewing cases for a Mirena IUD Class Action, MDL Lawsuit. If you have a perforated uterus from the Mirena IUD contact us today for a case review.

Birth control drugs and devices  have been the central focus  of lawsuits. Yaz, Yasmin, Beyaz, NuvaRing and the related Vaginal Mesh are just some of the birth control medications, devices and related women problem devices that are causing  injuries, death and destroying lives.
The Mirena IUD is being currently reviewed by our Mirena IUD lawyers. Mirena is manufactured by Bayer ,which also manufacturers Yaz and Beyaz. It is a flexible silicone  intrauterine device that is placed into the uterus through the vagina by a physician. Mirena releases a continuous dose of the hormone levonorgestrel to prevent pregnancy for up to five years.

The first-generation IUD Dalkon Shield was well known for its complications, including :infection, sepsis, miscarriage and even death. Ther Over 300,000 IUD  Dalkon Shield lawsuits were filed.

The problems Mirena IUD  lawyers are accepting  Mirena Silicone  IUD  cases for include puncture of the uterus or the device becoming firmly embedded in the uterus. This can cause bleeding and other serious complications. The device must have moved or gravitated, and can not be located. If you have had the device surgically removed we want to hear from you.

The vaginal mesh lawsuit trials are underway. Lawyers are beginning the depositions of key players. The clock is ticking File you vaginal mesh lawsuit now.


Vaginal mesh Horror, Vaginal mesh lawyers Filing Vaginal Mesh lawsuits

Written by Class Action Lawyer on . Posted in Multidistrict Lawsuit News

Vaginal mesh Lawyers Filing Lawsuits for Vaginal mesh MDL to Commence Soon

The United States Food and Drug Administration (FDA) has recently finished a review of the reports submitted by patients and providers and the most current scientific literature concerning transvaginal mesh surgery.   The results of the review showed that currently there is no evidence which supports the use of transvaginal mesh in transvaginal organ prolapse surgery versus the traditional non-mesh methods.   One of the major factors in coming to this conclusion is that there is an increased risk of complications when undergoing such repair procedures.

The FDA says in a recent alert that “Serious complications associated with surgical mesh for POP procedures and stress urinary incontinence (SUI) is not rare.”The FDA continues on by saying, “Furthermore, it is not clear that transvaginal POP repair with mesh is more effective than traditional non-mesh repair in all patients with POP and it may expose patients to greater risk.” 

The thousands of transvaginal mesh cases which the FDA reviewed were dated from 1996 through 2010, and the results that the FDA found that those patients who have had transvaginal pelvic organ prolapse repair with mesh are exposed to additional risks compared with those who have repair with stitches alone.  The results of the review also showed that, while the mesh did often times correct the anatomy; there was no greater clinical benefit over non-mesh surgery.  There were at least 100,000 pelvic organ prolapse repairs done in 2010 alone, and almost 75,000 of them were transvaginal procedures, according to statistics given by the FDA. According to the advice given by the FDA, doctors should be able to recognize that in many cases, pelvic organ prolapse can be treated without the use of mesh. The FDA also warned clinicians that mesh implants are permanent, and future repairs may be challenging, putting patients at risk for additional complications and surgeries.  Mesh that is placed abdominally, or used to treat SUI are not covered in the current FDA warning.

There has been, however a recent update on this issue:   “Based on assessment of Medical Device Reports (adverse event reports) submitted to the FDA, evaluation of the published literature, and the September 2011 Obstetrics-Gynecology Devices Panel meeting, the FDA is considering the recommendation that urogynecologic surgical mesh used for transvaginal repair of pelvic organ prolapse (POP) be reclassified from Class II to Class III.”


The Horrors of the vaginal mesh are Beyond Belief. Get a vaginal mesh lawyer today

Vaginal Mesh Lawsuit Updates | Vaginal Mesh lawyers Filing Lawsuits

Written by Class Action Lawyer on . Posted in Class MDL Class Action News

Vaginal mesh Lawyers  are Still filing lawsuits for woem with vaginal mesh Complications. You should not wait. There are statutes of limitations for your state that can effect your filing in the future:

Please note the statute of limitations below

Florida (4 years), Missouri (5 years), Nebraska (4 years), North Dakota (6 years), Utah (4 years) and Wyoming (4 years)
3 year SOL States D.C., Maryland, Massachusetts, Michigan, Mississippi, Montana, New Hampshire, New Mexico, North Carolina, Rhode Island, South Carolina, Vermont, Washington & Wisconsin

1 year (Kentucky, Louisiana & Tennessee)

non-discovery states (Arkansas, Indiana, Maine, New York & South Dakota)

Complications we hear appear to be similiar:

  • Erosion of the mesth thru the vagina wall
  • Infections  that doctors are not relating to the mesh
  • Spot bleeding
  • lower back pain
  • leg and pain on one side of the body
  • severe agonizing pain
  • Inability to have sexual intercourse
  • partners feeling the mesh
  • feeling pieceds of the mesh
  • doctors unsympathetic

YOu must see a Urogynecologist for your medical condition immediately and have a doctor acknowledge it is from the mesh.

You must not wait a retain an attorney immediately.